2015-09-20 | 5th Int. CeBiTec Research Conference Bielefeld

5^th Int. CeBiTec Research Conference

Drug Conjugates for Directed Therapy

Center for Interdisciplinary Research (ZiF), Bielefeld University, Germany

September 20 – 23, 2015

The Center for Biotechnology (CeBiTec) of Bielefeld University cordially invites you to attend the 5^th International CeBiTec Research Conference on "Drug Conjugates in Directed Therapy”.

CeBiTec Research Conferences are annual events with thematic focus on a challenging topic in the life sciences. The 2015 conference "Drug Conjugates for Directed Therapy" is being organized by the Marie Skłodowska-Curie European Training Network (ETN) MAGICBULLET, which is currently being funded by the EU in the Horizon 2020 Framework Programme for Research and Innovation.

The scope of the CeBiTec Research Conference will include:

• Antibody-Drug Conjugates
• Peptide-Drug Conjugates
• Targets and Specificity
• New Drugs
• Linker Technologies
• Applications
• Process Development

The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University from September 20^th to 23^rd, 2015.

Conference Schedule

Conference Flyer

Confirmed speakers

Jan Anderl	Heidelberg Pharma, DE
Antibody-Drug Conjugates Based on RNA Polymerase II Inhibiting Payloads
James Baker	University College London, UK
The Next Generation Maleimide platform for the construction of homogeneous protein conjugates
Annette Beck-Sickinger	Leipzig University, DE
Targeted cancer diagnosis and therapy with peptide conjugates
Ravi J. Chari	ImmunoGen, Waltham, US
Antibody-Drug Conjugates: Pathway from a concept to the clinic
Donald M. Engelman	Yale University, US
pHLIP® targeting and delivery of PNA in vivo to silence microRNA in acidic tumor cells
Cesare Gennari	Universitá degli Studi di Milano, IT
Tumor targeting via integrin ligands: Synthesis and biological evaluation of RGD peptidomimetic-Paclitaxel conjugates
Ulf Grawunder	NBE Therapeutics, CH
SMAC-Technology – generation of site-specifically conjugated ADCs by highly efficient enzymatic conjugation
Nicolas Joubert	Université de Tours, FR
A new chemical platform for the modular construction of homogeneous Antibody-Drug Conjugates
Horst Kessler	TU München, DE
Selective addressing integrin subtypes for drug research, molecular imaging and biophysical studies
Felix Kratz	CytRx Corporation, DE
Albumin-based drug delivery systems in oncology: From bench to bedside
Pirjo Laakkonen	Biomedicum Helsinki, FI
Peptide-based tumor targeting
Maxime Lampilas	Sanofi, Vitry sur Seine, FR
Process development of SPDB/DM4 conjugates
Hans-Georg Lerchen	Bayer, DE
Targeted drug conjugates: Challenges in the interface between small molecules and proteins
Marilena Manea	University of Konstanz, DE
Drug delivery systems containing GnRH-III peptide as a targeting moiety
Gábor Mező	MTA-ELTE, HU
Dual targeting with cyclic NGR peptides
Ines Neundorf	University of Cologne, DE
Design and application of cell-penetrating peptides as drug delivery vehicles
Umberto Piarulli	Università degli Studi dell'Insubria, IT
Synthesis and biological evaluation of integrin and dual integrin-VEGFR ligands for tumor targeting therapy
Doron Shabat	Tel Aviv University, IL
Distinct Developments in Linker Technologies for Bioconjugation
Fred Valeriote	Henry Ford Health System, Detroit, US
Discovery of anticancer leads as potential drug conjugates

You also may actively participate in the symposium by presenting your work in oral presentations (nearly ten time slots for 20 min oral communications are available) and poster presentations.

We look forward to your contribution!

Registration

Please register to the conference by using the ONLINE REGISTRATION.

Participation will be limited to 140 persons. The registration will be open till August 31^st, 2015.

Submission of Abstracts

Please submit your poster or short oral presentation abstract by using the online registration above.

Please apply for

Oral presentation: abstract submission by June 1^st, 2015

Poster presentation: abstract submission by August 24^th, 2015

Only .doc/.docx or .rtf files can be submitted.

For abstracts, please use the template provided HERE

Registration fee

Attendee's affiliation/status:

Until August 21^st, 2015		After August 21^st, 2015
Junior Scientist	€ 150	Junior Scientist	€ 200
Senior Scientist	€ 300	Senior Scientist	€ 350
Industry Attendee	€ 500	Industry Attendee	€ 600

(Junior scientist applies to: Students, PhD students, Postdoctoral research fellows max. two years after PhD graduation).

The registration fee covers the conference materials including book of abstracts, snacks, coffee and lunch as well as the conference dinner.

Please follow the payment details provided by the ONLINE REGISTRATION process.

Accommodation

You are encouraged to book your accommodation in the Park Inn conference hotel, which provide special rates for conference participants (available until August 21st, 2015).

Single bedroom (including breakfast): Euro 79,-

Double bedroom upon request

Please make your reservations mentioning group reference 24421 at

Park Inn by Radisson Bielefeld
Telephone: +49 521 9238-0
Fax: +49 521 9238-250
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Conference venue

The conference will be held at the Center for Interdisciplinary Research (ZiF) of Bielefeld University, Methoden 1, 33615 Bielefeld.

Travel Information

Detailed information on how to travel to Bielefeld and the Center for Interdisciplinary Research of Bielefeld University can be found HERE.

Further Information

For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

MAGICBULLET consortium and scientific committee of the 5th International CeBiTec Research Conference:

Cesare Gennari	Universitá degli Studi di Milano, IT
Pirjo Laakkonen	University of Helsinki, FI
Gábor Mező	Eőtvős Loránd University Budapest, HU
Ines Neundorf	University of Cologne, DE
Andreas Pahl	Heidelberg Pharma GmbH, Ladenburg, DE
Jan Anderl	Heidelberg Pharma GmbH, Ladenburg, DE
Umberto Piarulli	Universitá degli Studi dell’ Insubria, IT
Norbert Sewald	Bielefeld University (Co-ordinator), DE
Christian Steinkühler	Exiris, Rome, IT
József Tóvári	National Institute of Oncology, Budapest, HU

Acknowledgement

The 5^th International Bielefeld-CeBiTec Research Conference is jointly organised by the ETN MAGICBULLET, CeBiTec, Bielefeld University and the GFT e.V. (Gesellschaft zur Foerderung des Forschungs- und Technologietransfers in der Universitaet Bielefeld e.V.).

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642004.

Main Menu